Version: 1.0.0 | Published: 7 Jan 2026 | Updated: 52 days ago
Documentation
Description:
IMPORT HIGH is a phase 3, non-inferiority, open-label, randomised controlled trial that recruited women after breast-conserving surgery for pT1–3pN0–3aM0 invasive carcinoma from radiotherapy and referral centres in the UK. Clinical data and blood samples are available.
Coverage
Spatial:
United Kingdom
Typical Age Range:
23-87
Follow Up:
1 - 10 Years
Provenance
Origin
Purposes:
Trial
Sources:
Other
Collection Situations:
Cohort, study, trial
Temporal
Accrual Periodicity:
Static
Start Date:
24 June 2023
Time Lag:
Not applicable
Accessibility
Access
Access Rights:
Please contact the publisher using Contact Point details provided
Access Request Cost:
Not specified
Delivery Lead Time:
Other
Jurisdictions:
UK
Data Controller:
The Institute of Cancer Research
Data Processor:
The Institute of Cancer Research
Format and Standards
Vocabulary Encoding Schemes:
LOCAL
Conforms To:
LOCAL
Languages:
en
Formats:
In Progress